Effects of margarine and butter on lipid profile and serum fatty acid composition in rats

authors:

avatar Ali heshmati , * , avatar Ali asghar Vahidinia


how to cite: heshmati A, Vahidinia A A. Effects of margarine and butter on lipid profile and serum fatty acid composition in rats. koomesh. 2016;18(1):e151161. 

Abstract

Introduction: Cardiovascular disease is the leading cause of deathin the world. Nutritional factors are one of the main causes of these diseases. Food regimes that are rich in saturated and transfatty acids increase the risk of these diseases.The aim of this study was to investigate the impact of hard and soft margarine, butterand canola oil (control group) on serum lipid profileofrat. Materials and Methods: Thirty-two rats into four groups for eight weeks with a high-fat diet containing canola oil, hard and soft margarine or animal butter were fed. Fatty acid composition and lipid profile of serum were measured before and after the intervention. Results: Compared to canola oil, margarine and animal butter led to a significant increase in triglyceride. In all groups, total cholesterol and HDL-C were increased. Canola oil reduced LDL-C and hard margarine, but not soft margarine and also butter increased it. Butter increased LDL-C/HDL-C but margarine and canola oil reduced it. In serum of the control group, the levels of saturated fatty acids reduced, but those of mono- and poly-unsaturated fatty acids increased. The reverse changes  were found in the butter and margarine groups. Conclusion: In compared with butter, high-trans margarines have a negative impact on lipid profile, while low-trans  ones caused improvement lipid profile

References

  • 1.

    Sharifnia H, Haghdoost AA, Nazari R, Bahrami N, Soleimani MA, Pormand K. Relationship of risk factors and ST segment changes with symptoms of acute coronary syndrome. Koomesh 2013; 15: 46-53. (Persion).

  • 2.

    Attuquayefio T, Stevenson RJ. A systematic review of longer-term dietary interventions on human cognitive function: Emerging patterns and future directions. Appetite 2015; 95: 554-570.

  • 3.

    Crichton GE, Bryan J, Murphy KJ, Buckley J. Review of dairy consumption and cognitive performance in adults: findings and methodological issues. Dement Geriatr Cogn Disord 2010; 30: 352-361.

  • 4.

    Haug A, Hostmark AT, Harstad OM. Bovine milk in human nutrition-a review. Lipids Health Dis 2007; 6: 1-16.

  • 5.

    Livingstone KM, Lovegrove JA, Givens DI. The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies. Nut Res Rev 2012; 25: 193-206.

  • 6.

    Moore AH, Obanion M. Neuroinflammation and anti-inflammatory therapy for Alzheimers disease. Adv Drug Deliv Rev 2002; 54: 1627-1656.

  • 7.

    Ohlsson L. Dairy products and plasma cholesterol levels. Food Nut Res 2010; 54: 1-9.

  • 8.

    Zock PL, Katan MB. Butter, margarine and serum lipoproteins. Atherosclerosis 1997; 131: 7-16.

  • 9.

    Lecerf JM. Fatty acids and cardiovascular disease. Nut Rev 2009; 67: 273-283.

  • 10.

    Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010; 91: 535-546.

  • 11.

    Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 2014; 160: 398-406.

  • 12.

    Aune D, Norat T, Romundstad P, Vatten LJ. Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr 2013; 1066-1083.

  • 13.

    Engel S, Tholstrup T. Butter increased total and LDL cholesterol compared with olive oil but resulted in higher HDL cholesterol compared with a habitual diet. Am J Clin Nutr 2015; 102: 309-315.

  • 14.

    Beninc C, Zanoelo EF, de Lima Luz LF, Spricigo CB. Trans fatty acids in margarines marketed in Brazil: Content, labeling regulations and consumer information. Eur J Lipid Sci 2009; 111: 451-458.

  • 15.

    Masood A, Stark KD, Salem N, Jr. A simplified and efficient method for the analysis of fatty acid methyl esters suitable for large clinical studies. J Lipid Res 2005; 46: 2299-2305.

  • 16.

    Ghorbani R, Abtahi naeini B, Eskandarian R, Rashidy-Pour A, Khamseh ME, Malek M. Prevalence of metabolic syndrome according to ATPIII and IDF criteria in the Iranian population. Koomesh 2012; 14: 65-75. (Persion).

  • 17.

    Mohammadifard N, Hosseini M, Sajjadi F, Maghroun M, Boshtam M, Nouri F. Nouri F. Comparison of effects of soft margarine, blended, ghee, and unhydrogenated oil with hydrogenated oil on serum lipids: A randomized clinical trail. ARYA Atheroscler 2013; 9: 363-371.

  • 18.

    Ritvanen T, Putkonen T, Peltonen K. A comparative study of the fatty acid composition of dairy products and margarines with reduced or substituted fat content. Food Nut Sci 2012; 3: 1189-1196.

  • 19.

    Calder PC. Long-chain n-3 fatty acids and cardiovascular disease: further evidence and insights. Nut Res 2004; 24: 761-772.

  • 20.

    Haidari F, Tavakoli M, Heybar H, Helli B, Mohamadshahi M. The effect of omega-3 on the level of serum lipid profile, adipocytokines, and indicator of vascular inflammation in patients diagnosed with myocardial infarction. JBUMS 2015; 17: 7-17. (Persion).